PROVIDER PROFILE · NPI 1306884283
Michael MulliganMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
426
Unique beneficiaries
—
Total services
2,007
Distinct HCPCS
10
Medicare payment
$53K
Peer benchmark
Total Medicare services vs. 329 Allergy/ Immunology providers in CA — below median (cohort median 4,377).
PRESCRIBING · PART D · 2024
Total Rx claims
1,105
Beneficiaries
—
Total drug cost
$466K
Distinct drugs
29
Brand share
49.6%
Top prescribed drugs
Azelastine Hcl155 claims
Fluticasone Propionate136 claims
Fluticasone/Vilanterol72 claims
Albuterol Sulfate71 claims
Fluticasone Furoate45 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Michael Mulligan's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 2 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Edmund Tai Hematology-Oncology · Mountain View, CA | 40 | 189 |
| EL CAMINO HOSPITAL | 17 | 32 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Edmund Tai Hematology-Oncology · Mountain View, CA | 52 | 207 |
| EL CAMINO HOSPITAL | 14 | 28 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE